Medicenna Therapeutics Corp. Increase Decrease In Cash And Cash Equivalents
Medicenna Therapeutics Corp. (MDNAF) reported Increase Decrease In Cash And Cash Equivalents of CAD 13.06 million for the 3-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2023-06-27
- Medicenna Therapeutics Corp. increase decrease in cash and cash equivalents for the quarter ending 2023-03-31 was 13.06M CAD.
- Medicenna Therapeutics Corp. increase decrease in cash and cash equivalents for the quarter ending 2022-03-31 was -9.84M CAD, a 228.18% decline year-over-year.
- Medicenna Therapeutics Corp. increase decrease in cash and cash equivalents for the quarter ending 2021-03-31 was 7.68M CAD.
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2023-03-31 | 13.06M CAD 20-F · filed 2023-06-27 | |
| 2022-03-31 | -9.84M CAD 20-F · filed 2023-06-27 | -9.84M CAD 20-F · filed 2022-06-22 |
| 2021-03-31 | 7.68M CAD 20-F · filed 2023-06-27 | 7.68M CAD 20-F · filed 2022-06-22 |
| 2020-03-31 | 20.33M CAD 20-F · filed 2022-06-22 |